World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
95
Citations
38653
World Ranking
530
National Ranking
54

Gavin R. Screaton publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Gavin R. Screaton sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 339 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Gavin R. Screaton D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Gavin R. Screaton sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 95 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Research.com Recognitions

  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom

Overview

Gavin R. Screaton is affiliated with the University of Oxford in the United Kingdom. Their research primarily focuses on the field of Medicine, with an emphasis on Infectious Diseases, Molecular Biology, and Immunology. Additional areas of study include Public Health, Environmental and Occupational Health, as well as Animal Science and Zoology.

The scientist's work addresses several key topics, including:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 detection and testing
  • Animal Virus Infections Studies
  • Vaccines and immunoinformatics approaches
  • Mosquito-borne diseases and control
  • Monoclonal and Polyclonal Antibodies Research

Several notable recent papers authored by Gavin R. Screaton include:

  • Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19, 2020, Nature Immunology
  • Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera, 2021, Cell
  • Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers, 2020, New England Journal of Medicine
  • SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses, 2022, Cell
  • Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum, 2022, Cell

Gavin R. Screaton frequently collaborates with several co-authors, including:

  • Juthathip Mongkolsapaya
  • Wanwisa Dejnirattisai
  • David I. Stuart
  • Piyada Supasa
  • Chang Liu

The scientist publishes extensively in various journals. The most frequent publication venues are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Cell
  • SSRN Electronic Journal
  • The Lancet

Gavin R. Screaton has been recognized as a Fellow of The Academy of Medical Sciences, United Kingdom.

Best Publications

  • SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

    Unknown

  • Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.

    Gavin R. Screaton;Martyn V. Bell;David G. Jackson;Francois B. Cornelis

  • Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

    M Voysey;S A Costa Clemens;S A Madhi;L Y Weckx

  • Broad and strong memory CD4 + and CD8 + T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.

    Y Peng;A J Mentzer;G Liu;G Liu;X Yao

  • Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum

    Unknown

  • Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans

    Wanwisa Dejnirattisai;Amonrat Jumnainsong;Naruthai Onsirisakul;Naruthai Onsirisakul;Patricia Fitton

  • Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.

    D Zhou;W Dejnirattisai;P Supasa;C Liu

  • Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus

    Wanwisa Dejnirattisai;Piyada Supasa;Piyada Supasa;Wiyada Wongwiwat;Alexander Rouvinski

  • Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever.

    Juthathip Mongkolsapaya;Wanwisa Dejnirattisai;Xiao-ning Xu;Sirijitt Vasanawathana

  • Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers.

    S F Lumley;D O'Donnell;N E Stoesser;P C Matthews

  • Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study

    Unknown

  • Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.

    C Liu;H M Ginn;W Dejnirattisai;P Supasa

  • A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm

    Javier F. Cáceres;Gavin R. Screaton;Adrian R. Krainer

  • T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

    K J Ewer;Barrett;S Belij-Rammerstorfer;H Sharpe

  • Antibody evasion by the P.1 strain of SARS-CoV-2.

    W Dejnirattisai;D Zhou;P Supasa;C Liu

  • Structural basis of potent Zika–dengue virus antibody cross-neutralization

    Giovanna Barba-Spaeth;Wanwisa Dejnirattisai;Alexander Rouvinski;Marie Christine Vaney

  • A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus

    Wanwisa Dejnirattisai;Wiyada Wongwiwat;Sunpetchuda Supasa;Sunpetchuda Supasa;Xiaokang Zhang;Xiaokang Zhang

  • Role of the Modular Domains of SR Proteins in Subnuclear Localization and Alternative Splicing Specificity

    Javier F. Cáceres;Tom Misteli;Gavin R. Screaton;David L. Spector

  • T Cell Responses to Whole SARS Coronavirus in Humans

    Chris Ka Fai Li;Hao Wu;Huiping Yan;Shiwu Ma

  • MAIT cells are activated during human viral infections

    B van Wilgenburg;I Scherwitzl;E C Hutchinson;T Leng

  • Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.

    P Supasa;D Zhou;W Dejnirattisai;C Liu

  • TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL

    Gavin R. Screaton;Juthathip Mongkolsapaya;Xiao-Ning Xu;Alison E. Cowper

  • Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine (preprint)

    Voysey, Merryn, Costa Clemens, Sue Ann, Madhi, Shabir A.;Weckx, Lily Yin, Folegatti, Pedro M.;Parvinder K. Aley;Angus, Brian John, Baillie, Vicky, Barnabas, Shaun L.

Frequent Co-Authors

Juthathip Mongkolsapaya
Juthathip Mongkolsapaya University of Oxford
Wanwisa Dejnirattisai
Wanwisa Dejnirattisai University of Oxford
Prida Malasit
Prida Malasit National Science and Technology Development Agency
Xiao-Ning Xu
Xiao-Ning Xu Imperial College London
David I. Stuart
David I. Stuart University of Oxford
Miles W. Carroll
Miles W. Carroll University of Oxford
Derrick W. Crook
Derrick W. Crook University of Oxford
Paul Klenerman
Paul Klenerman University of Oxford
Philippa C. Matthews
Philippa C. Matthews University of Oxford
Félix A. Rey
Félix A. Rey Institut Pasteur

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career options beyond traditional laboratory roles. Many students explore related online degrees that complement their microbiology background, such as healthcare and information management fields.

For those interested in patient-focused careers, exploring functional medicine NP programs can provide a path to becoming a nurse practitioner specializing in holistic health approaches. This field integrates biological science knowledge with practical patient care.

Additionally, the healthcare sector relies heavily on accurate data management. Pursuing a degree in health information management can lead to rewarding roles with competitive compensation. Resources on health information management degree salary shed light on career outcomes in this fast-growing area.

Students interested in coding and billing can consider certification as a certified professional coder, which is crucial for healthcare administration and compliance.

When selecting online programs, it is important to verify accreditation. The best online cahiim accredited health information management degree programs list helps students find quality education approved by the Commission on Accreditation for Health Informatics and Information Management Education (CAHIIM).

Best Scientists Citing Gavin R. Screaton

Trending Scientists

Recently Published Articles